A Phase 1, Open-label Study to Investigate the Pharmacokinetics and Metabolism of GLPG1205 in Healthy Male Subjects Following Single Intravenous [14C]-GLPG1205 Microtracer and Single Oral [14C]-GLPG1205 Administration
Latest Information Update: 26 Mar 2021
At a glance
- Drugs GLPG 1205 (Primary) ; GLPG 1205 (Primary) ; GLPG 1205 (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Pharmacokinetics
- Sponsors Galapagos NV
- 24 Mar 2021 Status changed from recruiting to completed.
- 05 Feb 2021 Status changed from not yet recruiting to recruiting.
- 13 Jan 2021 New trial record